Description
While the assay measures peripheral LRRK2 activity for patient stratification, the relationship between neutrophil and brain LRRK2 kinase activity remains unestablished. This gap is critical for validating peripheral biomarkers as proxies for CNS pathology.
Gap type: open_question Source paper: Interrogating Parkinson’s disease LRRK2 kinase pathway activity by assessing Rab10 phosphorylation in human neutrophils. (2018, The Biochemical journal, PMID:29127255)
Resolution criteria
Resolution requires: (1) Prospective clinical study with n>=30 PD patients and n>=20 controls measuring neutrophil LRRK2 phosphorylation (S935 or S1292) and comparing to brain imaging (DaTscan or structural MRI) and CSF biomarkers (alpha-synuclein, neurofilament light chain); (2) Correlation threshold: peripheral LRRK2 activity correlates with brain dysfunction at r>=0.6, with peripheral activity explaining >=30% of variance in brain progression; (3) Intervention study: LRRK2 kinase inhibitor in PD patients (n>=10) showing peripheral activity decrease accompanied by matching changes in CSF or imaging biomarkers of brain dysfunction. Cross-sectional correlation without demonstrating peripheral changes reflect brain state is insufficient.
Evidence summary
{“resolution_pipeline”: “scidex.atlas.gap_closure_pipeline”, “task_id”: “f4f7b129-0f43-4c84-abd8-20d4e701842d”, “evaluated_at”: “2026-04-28T19:10:23.566693+00:00”, “resolution_summary”: “Resolved by hypothesis h-7000ac15c1: Therapeutic Window Exists Because Amplified Signals (Not Baseline) Drive Pathogenesis (H3). Supporting evidence includes debate sess_SDA-2026-04-16-gap-pubmed-20260410-170027-a1e5f867_20260416-135352.”, “match_counts”: {“hypothesis_matches”: 2, “debate_matches”: 5, “paper_matches”: 0}, “hypothesis_matches”: [{“id”: “h-7000ac15c1”, “title”: “Therapeutic Window Exists Because Amplified Signals (Not Baseline) Drive Pathogenesis (H3)”, “score”: 0.229, “reason”: “4 token overlaps; entity overlap: lrrk2”, “analysis_id”: “SDA-2026-04-23-gap-debate-20260417-033119-54941818”, “target_gene”: “LRRK2”, “target_pathway”: null, “disease”: “neurodegeneration”, “composite_score”: 0.78, “confidence_score”: 0.78, “status”: “proposed”, “pubmed_evidence_ids”: [“18687812”, “31694915”, “33106311”, “33812000”, “37849306”]}, {“id”: “h-a0269f3c81”, “title”: “G2019S Acts as Lysosomal Volume-Sensing Amplifier via Enhanced RAB29-Dependent Recruitment (H1)”, “score”: 0.223, “reason”: “4 token overlaps; entity overlap: lrrk2”, “analysis_id”: “SDA-2026-04-23-gap-debate-20260417-033119-54941818”, “target_gene”: “LRRK2,RAB29”, “target_pathway”: null, “disease”: “neurodegeneration”, “composite_score”: 0.73, “confidence_score”: 0.72, “status”: “proposed”, “pubmed_evidence_ids”: [“28165311”, “30635564”, “33135724”, “33177079”, “33448356”]}], “debate_matches”: [{“id”: “sess_SDA-2026-04-16-gap-pubmed-20260410-170027-a1e5f867_20260416-135352”, “title”: “While the study establishes LRRK2 as a lysosomal swelling sensor and notes that lysosomal swelling occurs in LRRK2-linked diseases, it doesn’t directly test whether pathogenic LRRK2 mutations alter this volume-sensing function. This connection is crucial for understanding how LRRK2 mutations cause Parkinson’s disease and related disorders.\n\nGap type: open_question\nSource paper: Lysosomal swelling triggers LRRK2 activity. (2026, bioRxiv : the preprint server for biology, PMID:41427358)”, “score”: 0.475, “reason”: “8 token overlaps; entity overlap: lrrk2, pmid”, “analysis_id”: “SDA-2026-04-16-gap-pubmed-20260410-170027-a1e5f867”, “quality_score”: 0.85, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-07-gap-pubmed-20260406-041445-ce0abc1e_task_73907230”, “title”: “The abstract states that AQP4 ‘is part of the pathogenesis’ of CNS disorders and shows ‘notable variability’ in these conditions, but the precise causal mechanisms linking AQP4 alterations to disease development remain unexplained. Understanding these mechanisms is critical for developing AQP4-targeted therapeutics.\n\nGap type: unexplained_observation\nSource paper: Aquaporin-4 in glymphatic system, and its implication for central nervous system disorders. (2023, Neurobiol Dis, PMID:36796590)”, “score”: 0.412, “reason”: “6 token overlaps; entity overlap: cns, pmid”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-041445-ce0abc1e”, “quality_score”: 0.757, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-07-gap-pubmed-20260406-041434-d7920f3b_task_9aae8fc5”, “title”: “While the study establishes P2RY12’s role in VSMC foam cell formation in atherosclerosis, the connection to brain vascular pathology and neurodegeneration remains unexplored. This gap is critical given P2RY12’s known roles in microglia and vascular cognitive impairment.\n\nGap type: open_question\nSource paper: The P2RY12 receptor promotes VSMC-derived foam cell formation by inhibiting autophagy in advanced atherosclerosis. (2021, Autophagy, PMID:32160082)”, “score”: 0.406, “reason”: “9 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-041434-d7920f3b”, “quality_score”: 0.623, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-16-gap-pubmed-20260411-082446-2c1c9e2d”, “title”: “The abstract explicitly questions whether AD’s hallmark pathologies induce cholinergic dysfunction or vice versa. This fundamental causality question is critical for determining therapeutic targets but remains unresolved despite evidence that β-amyloid affects cholinergic receptors.\n\nGap type: open_question\nSource paper: The cholinergic system in aging and neuronal degeneration. (2011, Behavioural brain research, PMID:21145918)”, “score”: 0.385, “reason”: “9 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-16-gap-pubmed-20260411-082446-2c1c9e2d”, “quality_score”: 0.95, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-12-20260411-082446-2c1c9e2d_20260412-210950”, “title”: “The abstract explicitly questions whether AD’s hallmark pathologies induce cholinergic dysfunction or vice versa. This fundamental causality question is critical for determining therapeutic targets but remains unresolved despite evidence that β-amyloid affects cholinergic receptors.\n\nGap type: open_question\nSource paper: The cholinergic system in aging and neuronal degeneration. (2011, Behavioural brain research, PMID:21145918)”, “score”: 0.385, “reason”: “9 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-12-20260411-082446-2c1c9e2d”, “quality_score”: 0.79, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}], “paper_matches”: []}